Nitric Oxide and Endothelin-1 in Pulmonary Hypertension
- 1 September 1998
- Vol. 114 (3), 208S-212S
- https://doi.org/10.1378/chest.114.3_supplement.208s
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in ratsJournal of the American College of Cardiology, 1996
- Behavioural abnormalities in male mice lacking neuronal nitric oxide synthaseNature, 1995
- Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrestSurgery, 1995
- Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repairThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1995
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Cell, 1994
- The endothelin system. A new target for therapeutic intervention.Circulation, 1994
- Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.Circulation Research, 1993
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed.Circulation Research, 1992